{"id":"https://openalex.org/W2273647343","doi":"https://doi.org/10.1093/jnci/36.5.859","title":"Effects of Immunosuppressants on Shope Rabbit Fibroma","display_name":"Effects of Immunosuppressants on Shope Rabbit Fibroma","publication_year":1966,"publication_date":"1966-05-01","ids":{"openalex":"https://openalex.org/W2273647343","doi":"https://doi.org/10.1093/jnci/36.5.859","mag":"2273647343"},"language":"en","primary_location":{"id":"doi:10.1093/jnci/36.5.859","doi":"https://doi.org/10.1093/jnci/36.5.859","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jnci/36.5.859","pdf_url":null,"source":{"id":"https://openalex.org/S98010888","display_name":"JNCI Journal of the National Cancer Institute","issn_l":"0027-8874","issn":["0027-8874","1460-2105"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JNCI: Journal of the National Cancer Institute","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109336480","display_name":"ANTHONY C. ALLISON","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4405285715","display_name":"National Institute for Medical Research","ror":"https://ror.org/00146rb91","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801081054","https://openalex.org/I4210087105","https://openalex.org/I4405285715","https://openalex.org/I90344618"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"A. C. Allison","raw_affiliation_strings":["National Institute for Medical Research, Mill Hill, London, England, and Pathologic Anatomy Branch, National Cancer Institute 2, Bethesda, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Institute for Medical Research, Mill Hill, London, England, and Pathologic Anatomy Branch, National Cancer Institute 2, Bethesda, Maryland","institution_ids":["https://openalex.org/I4210140884","https://openalex.org/I4405285715"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109118570","display_name":"Robert M. Friedman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4405285715","display_name":"National Institute for Medical Research","ror":"https://ror.org/00146rb91","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801081054","https://openalex.org/I4210087105","https://openalex.org/I4405285715","https://openalex.org/I90344618"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Robert M. Friedman","raw_affiliation_strings":["National Institute for Medical Research, Mill Hill, London, England, and Pathologic Anatomy Branch, National Cancer Institute 2, Bethesda, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Institute for Medical Research, Mill Hill, London, England, and Pathologic Anatomy Branch, National Cancer Institute 2, Bethesda, Maryland","institution_ids":["https://openalex.org/I4210140884","https://openalex.org/I4405285715"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5436,"currency":"USD","value_usd":5436},"apc_paid":null,"fwci":3.8719,"has_fulltext":false,"cited_by_count":29,"citation_normalized_percentile":{"value":0.93157628,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":0.32519999146461487,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":0.32519999146461487,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.26440000534057617,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.16089999675750732,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/methotrexate","display_name":"methotrexate","score":0.796999990940094},{"id":"https://openalex.org/keywords/cortisone","display_name":"cortisone","score":0.8960000276565552},{"id":"https://openalex.org/keywords/immunosuppression","display_name":"immunosuppression","score":0.9330000281333923},{"id":"https://openalex.org/keywords/tumor-regression","display_name":"tumor regression","score":0.8090000152587891},{"id":"https://openalex.org/keywords/delayed-type-hypersensitivity","display_name":"delayed-type hypersensitivity","score":0.8960000276565552},{"id":"https://openalex.org/keywords/humoral-immunity","display_name":"humoral immunity","score":0.5370000004768372},{"id":"https://openalex.org/keywords/cell-mediated-immunity","display_name":"cell-mediated immunity","score":0.9110000133514404},{"id":"https://openalex.org/keywords/interferon","display_name":"interferon","score":0.5680000185966492},{"id":"https://openalex.org/keywords/rabbits","display_name":"rabbits","score":0.621999979019165}],"concepts":[{"id":"https://openalex.org/C2780724051","wikidata":"https://www.wikidata.org/wiki/Q4667072","display_name":"Fibroma","level":2,"score":0.7877146005630493},{"id":"https://openalex.org/C2781059491","wikidata":"https://www.wikidata.org/wiki/Q422232","display_name":"Methotrexate","level":2,"score":0.6859428882598877},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5926195979118347},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5219128131866455},{"id":"https://openalex.org/C503630168","wikidata":"https://www.wikidata.org/wiki/Q178069","display_name":"Necrosis","level":2,"score":0.5041605234146118},{"id":"https://openalex.org/C3017924640","wikidata":"https://www.wikidata.org/wiki/Q7860879","display_name":"Delayed hypersensitivity","level":3,"score":0.4891989231109619},{"id":"https://openalex.org/C180032290","wikidata":"https://www.wikidata.org/wiki/Q1664296","display_name":"Inoculation","level":2,"score":0.4743351340293884},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4494844377040863},{"id":"https://openalex.org/C2778720950","wikidata":"https://www.wikidata.org/wiki/Q424972","display_name":"Prednisone","level":2,"score":0.4203590750694275},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.35700929164886475},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.32028043270111084},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.27624183893203735}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1093/jnci/36.5.859","doi":"https://doi.org/10.1093/jnci/36.5.859","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jnci/36.5.859","pdf_url":null,"source":{"id":"https://openalex.org/S98010888","display_name":"JNCI Journal of the National Cancer Institute","issn_l":"0027-8874","issn":["0027-8874","1460-2105"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JNCI: Journal of the National Cancer Institute","raw_type":"journal-article"},{"id":"pmh:oai:open-archive.highwire.org:jnci:36/5/859","doi":null,"is_oa":false,"landing_page_url":"http://jnci.oxfordjournals.org/cgi/content/short/36/5/859","pdf_url":null,"source":{"id":"https://openalex.org/S4406923041","display_name":"HighWire Press Open Archive","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"TEXT"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8560000061988831,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2347134106","https://openalex.org/W1832227764","https://openalex.org/W1917511631","https://openalex.org/W2398005555","https://openalex.org/W1938713630","https://openalex.org/W1544787286","https://openalex.org/W2471131947","https://openalex.org/W2290036071","https://openalex.org/W1507298703","https://openalex.org/W1557784459"],"abstract_inverted_index":{"In":[0,69,93],"adult":[1],"domestic":[2],"rabbits":[3,63],"treated":[4,96],"with":[5,97],"the":[6,23,39,49,57,78,91,94,127,142,166,169],"immunosuppressant,":[7],"Methotrexate,":[8],"which":[9],"blocks":[10],"delayed-type":[11,99],"hypersensitivity":[12,100],"and":[13,51,120],"antibody":[14,105,152],"formation,":[15],"regression":[16,89,128,167],"of":[17,45,73,80,90,109,129,155,168],"fibromas":[18,35,55,110,116,130,157],"was":[19,101,106,111],"retarded":[20,112],"so":[21],"that":[22,126],"tumors":[24],"became":[25],"much":[26],"larger":[27],"than":[28],"in":[29,141,165],"untreated":[30],"control":[31,62],"rabbits;":[32],"moreover,":[33],"secondary":[34,81,115,156],"developed":[36],"distant":[37],"from":[38],"original":[40],"inoculation":[41,59],"sites.":[42],"Second":[43],"injedions":[44],"fibroma":[46,143],"virus":[47],"on":[48],"5th":[50],"7th":[52],"days":[53],"induced":[54],"at":[56,66],"later":[58],"sites,":[60],"whereas":[61],"were":[64],"resistant":[65],"these":[67,119],"times.":[68],"Methotrexate-treated":[70],"rabbits,":[71],"administration":[72],"hyperimmune":[74],"antifibroma":[75],"serum":[76],"prevented":[77],"appearance":[79],"fibromas,":[82],"but":[83,103,113,145,158],"did":[84],"not":[85,132,160],"produce":[86],"necrosis":[87],"or":[88,136],"fibromas.":[92],"animals":[95],"cortisone,":[98],"suppressed":[102],"some":[104],"formed.":[107],"Regression":[108],"no":[114],"developed.":[117],"From":[118],"other":[121,138],"observations":[122],"it":[123],"is":[124,131],"concluded":[125],"due":[133],"to":[134,146],"interferon":[135],"any":[137],"Factor":[139],"inherent":[140],"cells":[144],"a":[147],"cell-mediated":[148],"immune":[149],"response.":[150],"Humoral":[151],"prevents":[153],"formation":[154],"does":[159],"play":[161],"an":[162],"important":[163],"part":[164],"primary":[170],"tumors.":[171]},"counts_by_year":[{"year":2015,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2016-06-24T00:00:00"}